Drawing for QUOTAAI

USPTO serial 99837102

QUOTAAI

Status 641Office Action
Filing date
May 21, 2026
Status date
Aug 11, 2026
Registration date
Examiner
MORRIS, ALINA S.

Need help with QUOTAAI?

CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Deadline: November 11, 2026

Office Action issues

The USPTO examiner has refused registration because the trademark is considered descriptive of your software and services, and has also requested clarification on the wording of your service descriptions.

Owner

  • MedRepOS, LLC

    WASHINGTON, DC, US

Goods and services

ClassDescriptionStatusFirst use
009Downloadable mobile applications for viewing sales intelligence data, tracking daily sales quota attainment, and managing surgical case schedules in the medical device industry; Downloadable mobile software for receiving artificial intelligence-generated prioritized account alerts and territory planning updatesACTIVE
042Providing temporary use of non-downloadable cloud-based software for sales intelligence, territory optimization, and revenue forecasting in the medical device industry; Providing a web-based platform featuring artificial intelligence for integrating data from CRM, ERP, and business intelligence systems to generate automated sales action plans; Providing non-downloadable software for tracking medical device capital equipment eligibility, GPO contract utilization, and surgical procedure volumesACTIVE

Prosecution history

DateCodeEvent
Aug 11, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 11, 2026GNRTNON-FINAL ACTION E-MAILED
Aug 11, 2026CNRTNON-FINAL ACTION WRITTEN
Jul 29, 2026DOCKASSIGNED TO EXAMINER
May 21, 2026MAFRAPPLICATION FILING RECEIPT MAILED
May 21, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 21, 2026NWAPNEW APPLICATION ENTERED

Related guidance